576 related articles for article (PubMed ID: 33529600)
1. Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning.
Drucker DJ
Cell Metab; 2021 Mar; 33(3):479-498. PubMed ID: 33529600
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 and Diabetes: A Comprehensive Review of Angiotensin Converting Enzyme 2, Mutual Effects and Pharmacotherapy.
Xie L; Zhang Z; Wang Q; Chen Y; Lu D; Wu W
Front Endocrinol (Lausanne); 2021; 12():772865. PubMed ID: 34867819
[TBL] [Abstract][Full Text] [Related]
3. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection.
Beyerstedt S; Casaro EB; Rangel ÉB
Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):905-919. PubMed ID: 33389262
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 infection impairs the insulin/IGF signaling pathway in the lung, liver, adipose tissue, and pancreatic cells via IRF1.
Shin J; Toyoda S; Nishitani S; Onodera T; Fukuda S; Kita S; Fukuhara A; Shimomura I
Metabolism; 2022 Aug; 133():155236. PubMed ID: 35688210
[TBL] [Abstract][Full Text] [Related]
5. Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era.
Ceriello A; Standl E; Catrinoiu D; Itzhak B; Lalic NM; Rahelic D; Schnell O; Škrha J; Valensi P;
Diabetes Care; 2020 Jul; 43(7):1427-1432. PubMed ID: 32409501
[TBL] [Abstract][Full Text] [Related]
6. Expression of the SARS-CoV-2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system.
Herman-Edelstein M; Guetta T; Barnea A; Waldman M; Ben-Dor N; Barac YD; Kornowski R; Arad M; Hochhauser E; Aravot D
Cardiovasc Diabetol; 2021 Apr; 20(1):90. PubMed ID: 33906662
[TBL] [Abstract][Full Text] [Related]
7. Diabetes, obesity and COVID-19: A complex interplay.
Vas P; Hopkins D; Feher M; Rubino F; B Whyte M
Diabetes Obes Metab; 2020 Oct; 22(10):1892-1896. PubMed ID: 32627299
[TBL] [Abstract][Full Text] [Related]
8. Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte.
D'Onofrio N; Scisciola L; Sardu C; Trotta MC; De Feo M; Maiello C; Mascolo P; De Micco F; Turriziani F; Municinò E; Monetti P; Lombardi A; Napolitano MG; Marino FZ; Ronchi A; Grimaldi V; Hermenean A; Rizzo MR; Barbieri M; Franco R; Campobasso CP; Napoli C; Municinò M; Paolisso G; Balestrieri ML; Marfella R
Cardiovasc Diabetol; 2021 May; 20(1):99. PubMed ID: 33962629
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).
Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H
J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199
[TBL] [Abstract][Full Text] [Related]
10. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19?
Hu Y; Liu L; Lu X
Front Endocrinol (Lausanne); 2021; 12():725967. PubMed ID: 34745001
[TBL] [Abstract][Full Text] [Related]
12. The implications of COVID-19 infection on the endothelium: A metabolic vascular perspective.
Dalan R; Boehm BO
Diabetes Metab Res Rev; 2021 Mar; 37(3):e3402. PubMed ID: 32871617
[No Abstract] [Full Text] [Related]
13. Angiotensin-converting enzyme 2, coronavirus disease 2019, and abdominal aortic aneurysms.
Xu B; Li G; Guo J; Ikezoe T; Kasirajan K; Zhao S; Dalman RL
J Vasc Surg; 2021 Nov; 74(5):1740-1751. PubMed ID: 33600934
[TBL] [Abstract][Full Text] [Related]
14. The Centrality of Obesity in the Course of Severe COVID-19.
Liu D; Zhang T; Wang Y; Xia L
Front Endocrinol (Lausanne); 2021; 12():620566. PubMed ID: 33776917
[TBL] [Abstract][Full Text] [Related]
15. A role of glycation and methylation for SARS-CoV-2 infection in diabetes?
Sartore G; Ragazzi E; Faccin L; Lapolla A
Med Hypotheses; 2020 Nov; 144():110247. PubMed ID: 33254553
[TBL] [Abstract][Full Text] [Related]
16. Viral infiltration of pancreatic islets in patients with COVID-19.
Steenblock C; Richter S; Berger I; Barovic M; Schmid J; Schubert U; Jarzebska N; von Mässenhausen A; Linkermann A; Schürmann A; Pablik J; Dienemann T; Evert K; Rodionov RN; Semenova NY; Zinserling VA; Gainetdinov RR; Baretton G; Lindemann D; Solimena M; Ludwig B; Bornstein SR
Nat Commun; 2021 Jun; 12(1):3534. PubMed ID: 34112801
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update.
Shukla AK; Banerjee M
High Blood Press Cardiovasc Prev; 2021 Mar; 28(2):129-139. PubMed ID: 33635533
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 Infections, Impaired Tissue, and Metabolic Health: Pathophysiology and Potential Therapeutics.
Singh SP; Bhatnagar A; Singh SK; Patra SK; Kanwar N; Kanwal A; Amar S; Manna R
Mini Rev Med Chem; 2022; 22(16):2102-2123. PubMed ID: 35105287
[TBL] [Abstract][Full Text] [Related]
19. Diabetes and COVID-19; A Bidirectional Interplay.
Kazakou P; Lambadiari V; Ikonomidis I; Kountouri A; Panagopoulos G; Athanasopoulos S; Korompoki E; Kalomenidis I; Dimopoulos MA; Mitrakou A
Front Endocrinol (Lausanne); 2022; 13():780663. PubMed ID: 35250853
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2-Indigenous Microbiota Nexus: Does Gut Microbiota Contribute to Inflammation and Disease Severity in COVID-19?
Chattopadhyay I; Shankar EM
Front Cell Infect Microbiol; 2021; 11():590874. PubMed ID: 33791231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
